Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus 50/500 µG/Inhalation; A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2015
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Orion
- 28 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Sep 2015 Planned End Date changed from 1 Apr 2015 to 1 Sep 2015 as per ClinicalTrials.gov record.
- 10 Sep 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Sep 2015 as per ClinicalTrials.gov record.